Centipeda orbicularis Lour.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | C. minima (Linn.) A.Br. & Asch. |
| Family | Compositae; Asteraceae. |
| Habitat | In damp places throughout the plains and low hills in India. |
| English | Sneezewort. |
| Ayurvedic | Kshavaka, Chhikkini, Chhikkikaa. |
| Folk | Nak-chhikani. |
| Action | Used for the treatment of rhinitis, sinusitis, nasopharyngeal tumors and obstructions, asthma and cold; also used in hemicrania. |
| Dosage | Seed—1–3 g powder. (CCRAS.) |
| Taxonomic Cohort | Genus Centipeda (1 documented species); Family Compositae (91 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Centipeda orbicularis (taxonomically cited with authority Lour.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Compositae; Asteraceae (primary family classification: Compositae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. minima (Linn.) A.Br. & Asch, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: In damp places throughout the plains and low hills in India.
Across classical and vernacular Indian systems of medicine, Centipeda orbicularis is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Sneezewort; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Kshavaka, Chhikkini, Chhikkikaa; in regional Indian folk and vernacular ethnobotany as Nak-chhikani. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Centipeda orbicularis are: Used for the treatment of rhinitis, sinusitis, nasopharyngeal tumors and obstructions, asthma and cold; also used in hemicrania. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Centipeda orbicularis establish the following evidence base: The plant extract showed a good antitussive and expectorant activity on mice. The flavonoids, sesquiterpenes and amide exhibited significant antiallergy activity in passive cutaneous anaphylaxis (PCA) test.
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Centipeda orbicularis stands as a distinct representative of the genus Centipeda. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Compositae encompasses 91 documented medicinal species (5.02% of the 1,814-species flora). Other representative medicinal members of Compositae include: Acanthospermum hispidum (Trikantaka), Achillea millefolium (Milfoil), Ainsliaea aptera (Karui Buuti), Amberboa divaricata (Brahmadandi), Anacyclus pyrethrum (Aakaarakarabha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 91 medicinal species of family Compositae.
5. Pharmacopoeial Standards, Posology & Reference Framework
For clinical and traditional dispensing, the standardized posology and crude herb dosage for Centipeda orbicularis are prescribed as follows: Seed—1–3 g powder. (CCRAS.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Centipeda orbicularis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.